首页> 外文OA文献 >Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.

【2h】

Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.

机译：药物代谢酶基因多态性对抗结核药物性肝损伤风险的药物遗传学研究：荟萃分析。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yu Cai; JiaYong Yi; ChaoHui Zhou; XiZhong Shen;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Association of POR and PPAR alpha polymorphisms with risk of anti-tuberculosis drug-induced liver injury in Western Chinese Han population [J] . Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases . 2020,第期

机译：POR和PPARα多态性与抗结核药物诱导的西方汉族人群肝损伤的关联
2. Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study [J] . Shixian Chen, Hongqiu Pan, Yongzhong Chen, Scientific reports. . 2019,第1期

机译：NRF2，Keap1，MAFF，MAFK和抗结核病药物诱导肝损伤的遗传多态性之间的关联：嵌套病例对照研究
3. CYP2E1 RsaI/PstI polymorphism and risk of anti-tuberculosis drug-induced liver injury: a meta-analysis [J] . Deng R., Yang T., Wang Y., The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease . 2012,第12期

机译：CYP2E1 RsaI / PstI基因多态性与抗结核药物性肝损伤的风险：一项荟萃分析
4. Study on the interaction between polymorphisms of metabolic enzyme genes and environmental risk factors to lung cancer in Nanjing population [C] . . 2004

机译：南京市人群代谢酶基因多态性与环境危险因素相互作用的研究。
5. Involvement of Th17 Pathway in Adverse Drug Reactions: Mechanistic Investigation of Drug-Induced Autoimmunity and Drug-induced Liver Injury. [D] . Zhu, Ervin Xu. 2012

机译：Th17途径参与药物不良反应：药物诱发的自身免疫和药物诱发的肝损伤的机制研究。
6. Pharmacogenetic Study of Drug-Metabolising Enzyme Polymorphisms on the Risk of Anti-Tuberculosis Drug-Induced Liver Injury: A Meta-Analysis [O] . Yu Cai, JiaYong Yi, ChaoHui Zhou, -1

机译：有关抗结核病药物性肝损伤的风险药物代谢酶基因多态性的遗传药理学研究的meta分析
7. Involvement of cytochrome P450 1A1 and glutathione S-transferase P1 polymorphisms and promoter hypermethylation in the progression of anti-tuberculosis drug-induced liver injury: a case-control study. [O] . Lei He, Li Gao, Zhe Shi, 2015

机译：参与细胞色素p450 1a1和谷胱甘肽s-转移酶p1多态性和启动子高甲基化在抗结核药物诱导的肝损伤的进展中：病例对照研究。
8. Data-Driven Identification of Structural Alerts for Mitigating the Risk of Drug-Induced Human Liver Injuries. [R] . Liu, R., Yu, X., Wallqvist, A. 2015

机译：结构警报的数据驱动识别，以减轻药物引起的人类肝损伤的风险。

Pharmacogenetic study of drug-metabolising enzyme polymorphisms on the risk of anti-tuberculosis drug-induced liver injury: a meta-analysis.

著录项

引文网络

相似文献

相关主题

期刊订阅